Adjuvant chemotherapy options for early stage non-small cell lung cancer
For many years adjuvant chemotherapy has been a standard treatment after complete resection in malignancies such as breast and colon but only recently has its use become standard in early stage non-small cell lung cancer (NSCLC). Although surgery is regarded as the best possible treatment for early...
Main Authors: | Manali ePatel, Heather A Wakelee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2011-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2011.00045/full |
Similar Items
-
Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01) -
The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01) -
A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma
by: Chen SHEN, et al.
Published: (2022-08-01) -
Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer
by: Takahiro Mimae, et al.
Published: (2022-01-01) -
Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer
by: Guilherme Harada, et al.
Published: (2021-02-01)